H.J. Res. 197 (119th)Bill Overview

Disapprove HHS 2027 ACA Benefit and Payment Rule

CRA Disapprovaldomestic policy
Cosponsors
Support
Democratic
Introduced
Jun 18, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
CRA DisapprovalWhat this resolution actually does

Congress is using the Congressional Review Act to overturn a final rule issued by HHS/CMS concerning the Notice of Benefit and Payment Parameters for 2027 and the Basic Health Program. The resolution would nullify that rule and, if enacted, would prevent the agency from issuing a substantially similar rule without new legislation. The CRA provides an expedited process in the Senate and allows Congress to disapprove a rule by simple majority.

Rule targeted

Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (91 Fed. Reg. 29526 (May 20, 2026)).

Issuing agency

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS)

Passage rules

Under the Congressional Review Act, the Senate may consider this disapproval under expedited procedures that prevent a filibuster and allow passage by a simple majority; both chambers must pass the joint resolution and the President must sign it to nullify the rule. A presidential veto could be overridden only by the required congressional majority.

This joint resolution invokes the Congressional Review Act to disapprove a Centers for Medicare & Medicaid Services rule titled "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program" (91 Fed.

Reg. 29526, May 20, 2026).

If enacted, the resolution would render that CMS rule null and void and prevent it from taking effect.

Passage35/100

Narrow and procedurally simple but touches a highly contentious federal health policy; success hinges on chamber majorities and timing under CRA rules.

CredibilityAligned

Relative to its intended legislative type, this bill is a straightforward Congressional Review Act disapproval resolution that unambiguously identifies the administrative rule and declares it to have no force or effect.

Contention62/100

Progressives emphasize preserving ACA implementation and consumer protections.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
ConsumersFederal agencies · States

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitReasserts Congressional oversight over major health program rules through the Congressional Review Act.
  • ConsumersPrevents CMS changes supporters argue could increase consumer premiums or reduce marketplace subsidies.
  • Potential benefitMaintains existing regulatory baseline, avoiding immediate administrative changes for insurer compliance.
Likely burdened
  • Federal agenciesBlocks CMS updates that may have been intended to stabilize premiums or reduce federal costs.
  • StatesCreates uncertainty for insurers and states that were planning for 2027 parameters announced in the rule.
  • ConsumersMay prevent adoption of consumer protections or coverage-expanding provisions included in the rescinded rule.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize preserving ACA implementation and consumer protections.
Progressive15%

Likely opposed to the joint resolution because it would nullify an HHS rule implementing Affordable Care Act parameters and Basic Health Program provisions.

Democrats and progressives generally favor preserving regulatory protections and coverage-supporting rules absent clear harm.

Likely resistant
Centrist50%

Mixed view: sees procedural legitimacy in using the CRA, but worries about operational disruption without clear, specific justification.

Would weigh demonstrated fiscal and beneficiary impacts before supporting disapproval.

Split reaction
Conservative75%

Likely supportive of disapproval, viewing it as a check on federal regulatory expansion under the ACA and a way to curb HHS rulemaking authority.

Prefers limiting federal mandates and promoting state control.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Narrow and procedurally simple but touches a highly contentious federal health policy; success hinges on chamber majorities and timing under CRA rules.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Which party or coalition controls each chamber during consideration
  • Whether the CRA 60-legislative-day window for disapproval remains valid
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize preserving ACA implementation and consumer protections.

Narrow and procedurally simple but touches a highly contentious federal health policy; success hinges on chamber majorities and timing unde…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward Congressional Review Act disapproval resolution that unambiguously identifies the administrative rule and declares it to have no force or effect.

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis